Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC May 10, 2019 7:24pm EDT
Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019 Apr 24, 2019 7:30am EDT
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019 Apr 23, 2019 7:30am EDT
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference Apr 02, 2019 7:00am EDT
Aptose Presents New Preclinical Data on CG-806 and APTO-253 at the 2019 AACR Annual Meeting Apr 01, 2019 1:00pm EDT
Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806 Mar 25, 2019 7:02am EDT
Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2018 Mar 12, 2019 4:02pm EDT
